Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

No Hesitation -- Patient Perspectives Clinical Trials Storytelling 2023-24
Amy Whitecotton shares her story for the Patient Perspectives Clinical Trials Storytelling 2023-24 Program.
Author
Denise Brock
Image
Amy Whitecotton Patient Perspectives

Amy’s story is shared as part of the Patient Perspectives - Clinical Trials Experiences Storytelling Program


This program aims to give those diagnosed with cancer a voice to share their experiences participating in clinical trials and help others understand the importance of participating in clinical trials.  To view the full playlist of videos from the Patient Perspectives - Clinical Trials Storytelling Program, please visit the full playlist for this program here

 

"No Hesitation" is Amy's story.

 

Diagnosed with Invasive Ductal Carcinoma (Triple Negative) in the fall of 2020, Amy was asked at her diagnosis if she would be willing to participate in a clinical trial, and she immediately agreed without hesitation.  She has participated in the ARTEMIS trial through MD Anderson, and a trial of Enzalutamide and Paclitaxel Before Surgery.  She has also participated in mental health studies and trials specifically for people who have been through a cancer diagnosis, through Stanford Cancer Center.  This study worked to help understand how your mindset might affect one's health and well-being.  She continues to participate in a study called Breaking Through the Brain Fog at the University of Texas at Dallas, focusing on education, exercises, and strategies to support brain health.  

 

Amy's story is one of success, and not hesitating to move forward with clinical trials that saved her life.

 

A huge thanks to our sponsors! #exelixis #lilly #merck #blueprintmedicines

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi Stan,

It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving.  I know it meant a...

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine that family and friends - our chosen family...

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Recent Comments

JOIN THE CONVERSATION
So good to hear from you Stan
By dbrock on
Hi Stan,

It's so good to…
By JanineT GRACE … on
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on